Search

Investors, business leaders, employees, and the general public increasingly care about environmental, social, and corporate governance issues. Learn about ESG, why boards should care, and next steps.

The question that this insight into RWI answers is: Do these policies actually pay claims? Read more for information about the Lowenstein Sandler survey results, RWI pricing, claims, and the impact of COVID-19.

In this update, read more about COVID-19 and other impacts on RWI pricing, deal flow, minority investments, and more.

The D&O Market for foreign IPO companies looking to list on US exchange has largely collapsed. Our foreign filers expert, Jane Njavro, offers insight and practical suggestions for how to handle foreign filer D&O insurance renewals in the current landscape.

The EU-US Privacy Shield no longer provides operation benefits, though the risk has not changed. Read more about compliance and how cyber insurance can enable companies to privacy transfer risk.

After proposing new rules last year, the SEC's final rule imposes new oversight on proxy advisory firms.

Learn more about how derivative suit litigation is impacting the cost of Side A insurance, what Side A insurance coverage is, and how much of it you may want to purchase.

The theme of the year is a hardening market. On the casualty side there has been an explosion of large liability claims and reductions in excess liability capacity.

Here are three critical cyber risks that both companies with a high volume of records and alternative investment managers need to know.

The recent Clovis Oncology case is a cautionary tale that provides insights into what Delaware courts expect from directors when it comes to corporate oversight.

President Trump issued several Executive Orders intending to lower prescription drug costs.